Related Experiment Video

Updated: Jul 14, 2026

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
06:31

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

New developments of aminobisphosphonates: the double face of Janus

D Santini1, S Galluzzo, B Vincenzi

  • 1Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy. d.santini@unicampus.it

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|September 27, 2007
PubMed
Abstract

Insights

Bisphosphonate (BP) therapy shows promise in preventing bone loss and disease in early-stage cancer patients. This review explores preclinical and clinical evidence, including zoledronic acid (ZA) effects on survival and metastasis prevention.

Area of Science:

  • Oncology
  • Pharmacology
  • Bone Biology

Background:

  • Bisphosphonate (BP) therapy is a standard treatment for malignant bone disease.
  • Preclinical and early clinical data suggest BPs can prevent cancer treatment-induced bone loss.
  • BPs may also prevent the onset of malignant bone disease in early-stage cancer.

Purpose of the Study:

  • To review preclinical evidence of BP action on osteoclasts and tumor cells.
  • To report the effects of BPs on skeletal disease progression in various cancers.
  • To analyze preliminary clinical data and ongoing trials on zoledronic acid (ZA).

Main Methods:

  • Review of preclinical studies on bisphosphonates.
  • Analysis of clinical data from retrospective trials of zoledronic acid (ZA).
  • Examination of ongoing adjuvant phase III trials for ZA.

Main Results:

  • Preclinical data support BP efficacy against osteoclasts and tumor cells.
  • Clinical data suggest ZA may impact survival in cancer patients.
  • Ongoing trials are investigating ZA's role in adjuvant therapy.

Conclusions:

  • Preliminary clinical evidence from prospective studies indicates ZA's potential.
  • ZA treatment may be effective in preventing bone metastasis.
  • Further research and clinical trials are warranted to confirm these findings.

More Related Videos

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...